Sucroferric oxyhydroxide (PA21)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sucroferric oxyhydroxide (PA21), covering 2019-07-22 to 2019-07-22. Get the full timeline:
Most recent: Clinical Trial Update: The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum [Phase 2]